FNY Investment Advisers’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

FNY Investment Advisers’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,100	Closed	–	–	1248
2025 Q1	$0	Buy	16,100 +11,000	+216%	+$1.85K	﹤0.01%	1050
2024 Q4	$1K	Buy	+5,100	New	+$6.12K	﹤0.01%	646

FNY Investment Advisers's SYRS Position: Q2 2025 in Review

FNY Investment Advisers sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2025, closing a stake of 16,100 shares.

FNY Investment Advisers first reported a position in SYRS in Q4 2024 and held it in 2 quarters. The position peaked at $1K in Q4 2024. 0 funds tracked by Wall St. Rank hold SYRS as of Q2 2025.

FNY Investment Advisers reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
FNY Investment Advisers sold 16,100 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2025.
FNY Investment Advisers first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
FNY Investment Advisers's Syros Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q4 2024.
0 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2025.

Based on FNY Investment Advisers's 13F filing for Q2 2025, filed 30 Jul 2025.